QuickView for MED12 protein

1. Colorectal cancer HCT116 wildtype or CRISPR/Cas9-mediated MED12 knock-in cells treated with IFNg
2. Breast cancer MCF7 cells MED12 or SMC3 knockdown and estrogen treatment

1. Quality of life after myomectomy according to the surgical approach and MED12 mutation status.
2. Somatic MED12 Mutations in Myometrial Cells.
3. Establishment of a human induced pluripotent stem cell line, KMUGMCi010-A, from a patient with X-lin…
4. MED12 variants associated with X-linked recessive partial epilepsy without intellectual disability.
5. Extensive blaschkoid hypopigmentation in a girl with MED12-related disorder.

There were no clinical trials for MED12 protein